Inhibitor Report for: SCHEMBL20516363IC50 value lower than 100 nM for ABHD6 and between 100 nM and 1 microM for Lp-PLA2 WO-2017059135 patent by Abide Therapeutics, Inc General | Type | | Piperazine, Imidazol, Carbamate, Morpholine | | Chemical_Nomenclature | | [(4R)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl] 4-[2-chloro-3-(morpholine-4-carbonyl)phenyl]piperazine-1-carboxylate | | Canonical SMILES | | CC(C)C1C(=O)N(C(=O)N1)OC(=O)N2CCN(CC2)C3=CC=CC(=C3Cl)C(=O)N4CCOCC4 | | InChI | | InChI=1S/C22H28ClN5O6/c1-14(2)18-20(30)28(21(31)24-18)34-22(32)27-8-6-25(7-9-27)16-5-3-4-15(17(16)23)19(29)26-10-12-33-13-11-26/h3-5,14,18H,6-13H2,1-2H3,(H,24,31)/t18-/m1/s1 | | InChIKey | | MAAXHKBCVMPHBI-GOSISDBHSA-N
| | Other name(s) | | SCHEMBL20516418 ; SCHEMBL20516364 |
________________________________________________________________________________________________ |
|
